|
TRAX First Tracks Biotherapeutics Inc 2091349 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-33,374,000.00 |
| Balance Sheet |
|
Current Assets
|
$177,745,000.00 |
|
Assets
|
$183,140,000.00 |
|
Current Liabilities
|
$12,447,000.00 |
|
Equity
|
$168,796,000.00 |
|
Shares Out
|
35730843.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-64,479,000.00 |
|
Investing Cash Flow
|
$34,958,000.00 |
| Market Analysis |
Market Cap
|
$1,497,122,321.70 |
|
Price
|
$38.60 |
|
BVPS
|
4.72 |
|
PB
|
8.88 |
|
EPS
|
-0.95 |
|
FCF
|
$-64,521,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:28 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TRAX documents filed with the SEC.
TRAX Filings
Clear
